Medical devices, healthcare technology and the business of care
510(k) clearance · K251207

Sangria Thrombectomy System

Avantec Vascular Corporation · Decision date Jan 7, 2026

FDA DECISIONK251207

What did the FDA decide?

FDA records K251207 as a 510(k) premarket notification, with a decision dated Jan 7, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Jan 7, 2026

FDA source record

Regulatory record facts

Identifier
K251207
Regulatory pathway
510(k) premarket notification
Product code
QEW
Decision code
SESE
Decision date
Jan 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.

Product code
QEW
FDA device class
2

FDA decision timeline

  1. K251207 received

    Application receipt date recorded by FDA.

  2. K251207 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QEW

Product / regulatory recordCompanyPathwayDecision dateSource
Penumbra Inc.510(k) clearanceOct 15, 2026FDA
Inari Medical, Inc.510(k) clearanceSep 18, 2026FDA
Endovascular Engineering510(k) clearanceSep 3, 2026FDA
Inari Medical, Inc.510(k) clearanceAug 21, 2026FDA
Jupiter Endovascular510(k) clearanceAug 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Avantec Vascular Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sunnyvale, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records